| Jul 12 |
Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan
|
| Jul 12 |
Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
|
| Jul 10 |
Arcutis bags FDA approval for atopic dermatitis cream after delay
|
| Jul 10 |
Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
|
| Jul 10 |
FDA Approves Expanded Use Of Arcutis Biotherapeutics' Eczema Drug For Patients As Young As 6 Years
|
| Jul 10 |
AbbVie names new R&D head; Arcutis eczema cream approved
|
| Jul 9 |
Arcutis gets FDA approval for Zoryve for atopic dermatitis
|
| Jul 9 |
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
|
| Jul 9 |
Arcutis says FDA still working on action letter for roflumilast
|
| Jul 9 |
Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis
|
